Journals / Journal of Neurological Sciences (Turkish) / 2012 / Cilt: 29 - Sayı: 3

Rat Pineal ve Hipofiz Bezlerinde Metilfenidata Bağlı Olarak Oluşan İmmünohistokimyasal ve İnce Yapısal Değişiklikler: Doz Bağımlı Çalışma

Immunohistochemical and Ultrastructural Changes Related To Methylphenidate In Rat Pituitary and Pineal Glands

Pages
476–493
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, we suggest that the therapeutic dose of methylphenidate must be kept inminimum level.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The presence of a dopaminergic function in pituitary and pineal glands is wellknown.
📊
Key Findings & Data:Our aim is toinvestigate dose-dependent immunohistochemical dopamine 2 expression, possible cellapoptosis and ultrastructural changes of the rat pituitary and pineal gland tissue, todemonstrate possible toxicity of the chronic extended use of the MPH.Material and Methods: In this study, 27 female prepubertal Wistar albino rats, divided intothree different dose groups (5, 10 and 20 mg/kg), were treated orally with MPH dissolved insaline solution for 5 days per week during three months.
💡
Conclusion & Impact:Thus, we suggest that the therapeutic dose of methylphenidate must be kept inminimum level.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The presence of a dopaminergic function in pituitary and pineal glands is wellknown. Methylphenidate (MPH), a widely prescribed psychostimulant for attentiondeficit/hyperactivity disorder, is an indirect dopamine agonist which could have the capacityof influencing the hypothalamo-neurohypophysial system with the pineal gland. Our aim is toinvestigate dose-dependent immunohistochemical dopamine 2 expression, possible cellapoptosis and ultrastructural changes of the rat pituitary and pineal gland tissue, todemonstrate possible toxicity of the chronic extended use of the MPH.Material and Methods: In this study, 27 female prepubertal Wistar albino rats, divided intothree different dose groups (5, 10 and 20 mg/kg), were treated orally with MPH dissolved insaline solution for 5 days per week during three months. At the end of the third month, afterperfusion fixation, pituitary and pineal glands were removed and sections were collected forimmunohistochemical, TUNEL assay and ultrastructural studies.Results: We observed that methylphenidate induced dose-related ultrastructural changes inpituitary and pineal glands.Conclusion: High dose administration of this drug could influence the functions of theseglands. Thus, we suggest that the therapeutic dose of methylphenidate must be kept inminimum level.

Özet

Amaç: Metilfenidat (MPH), dikkat eksikliği/hiperaktivite bozukluğu için oldukça sıkreçetelenen psikostimulan bir ilaç olup dolaylı dopamine agonist etkisi üzerinden, pineal vehipofiz bezlerindeki varlığı bilinen dopaminerjik fonksiyonlar nedeni ile hipothalamo- nörohipophysial sistemi ve pineal bezi etkileyebilecek kapasiteye sahip görülmektedir.Metilfenidatın kronik uzun süreli kullanımı nedeniyle oluşabilecek toksisiteyi gösterebilmekamacıyla, doz bağımlı dopamine 2 ekspresyonunda gelişebilecek değişiklikler, olası hücreölümü ve ince yapısal değişiklikler araştırılmıştır.Materyal ve Metod: Çalışmada Wistar albino tipi 24 adet prepubertal sıçana (5,10 ve 20mg/kg) üç ay boyunca, haftada 5 gün oral yolla serum fizyolojik içersinde çözünmüşMetilfenidat uygulanıldı. Kontrol grubuna serum fizyolojik verildi. Uygulamanın üçüncüayında perfüzyon tespiti sonrasında pineal ve hipofiz dokuları alındı ve kesitlerimmünohistokimyasal, TUNEL ve elektron mikroskopik incelemeler için toplandı.Bulgular: Metilfenidat, doza bağımlı olarak hipofiz ve pineal bez dokusunda ince yapısaldeğişikliklere neden olmaktadır.Sonuç: Bu ilacın yüksek dozlarda kullanımı, bu bezlerin fonksiyonlarını etkileyebilir.Dolayısıyla, metilfenidatın tedavi edici dozlarının minimum düzeylerde tutulmasının daha iyiolacağı kanısındayız.

🔖

Cite This Article

GÖZİL, R., ÇALGÜNER, E., ŞENER, D., TAKE, G., ERDOĞAN, D., BAHCELIOĞLU, M., ELMAS, Ç. (2022). Rat Pineal ve Hipofiz Bezlerinde Metilfenidata Bağlı Olarak Oluşan İmmünohistokimyasal ve İnce Yapısal Değişiklikler: Doz Bağımlı Çalışma. Journal of Neurological Sciences (Turkish), Cilt: 29 - Sayı: 3, 476–493. https://ajindex.com/articles/565299

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Aktaş Z, Cansi A, Erdogan D, Take G, Goktas G, et al. Retinal ganglion cell toxicity due to oxcarbazep ine and valp roic acid treatment in rat. Seizure 2000; 18: 396-99
  2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, f ourth ed., text revision. 2000
  3. Amini B, Yang PB, Swann AC, Daf ny N. Diff erential locomotor resp onses in male rats f rom three strains to acute methylp henidate. Intern J Neurosci 2004; 114: 1063-84
  4. App enrodt E, Boj anowska E, Janus J, et al. Eff ects of Methylp henidate on oxytocin and vasop ressin levels in p inealectomized rats during light–dark cycle. Pharmacol Biochem ad Behav 1997; 58: 415- 19
  5. App enrodt E, Schwarzberg H. Methylp henidate- induced motor activity in rats: modulation by melatonin and vasop ressin. Pharmacol Biochem and Behav 2003; 75: 67-73
  6. Axelrod J, Shein HM, Wurtman RJ. Stimulation of 14C-melatonin synthesis f rom 14C-tryp top han by noradrenaline in rat p ineal in organ culture. Proc Natl Acad Sci 1969; 62: 544-49
  7. Bahcelioglu M, Gozil R, Take G, Elmas C, Oktem H, et al. Dose-related immunohistochemical and ultrastructural changes af ter oral methylp henidate administration in cerebrum and cerebellum of the rat. World J Biol Psychiatry 2009; 10: 531- 43
  8. Barden N, Chevillard JM, Saavedra JM. Diurnal variation in rat p osterior p ituitary catecholamine levels. Neuroendocrinology 1982; 34: 148
  9. Ben-Jonathan N. Dop amine: a p rolactin-inhibiting hormone. Endocrine Reviews 1985; 6: 564-589
  10. Bj orklund A, Falck B, Nobin A, Stenevi V. Organization of the dop amine and noradrenaline innervations of the median eminence-p ituitary region in the rat. Neurosecretion 1973;1:209
  11. Bj orklund A, Moore RY, Nobin A, Stenevi V. The organization of the tubero-hyp ophysial and reticulo- inf undibular catecholamine neuron system in the rat brain. Brain Res 1973; 51: 171-91
  12. Blanchard DC, Shep herd JK, De Padua Carobrez A, Blanchard RJ. Sex eff ects in def ensive behavior: Baseline diff erences and drug interactions. Neurosci Biobehav Rev 1991; 15: 461-68
  13. Brandon CL, Marinelli M, Baker LK, White FJ. Enhanced reactivity and vulnerability to cocaine f ollowing methylp henidate treatment in adolescent rats. Neuropsychop harmacology 2001; 25: 651-661
  14. Brandon CL, Marinelli M, White FJ. Adolescent exp osure to methylp henidate alters the activity of rat midbrain dop amine neurons. Biol Psychiatry 2003; 54: 1338–44
  15. Brandon CL, Steiner H. Rep ea